% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • networthdev networthdev Dec 19, 2012 7:20 PM Flag

    Amgen validation, they NEED more IMGN

    Yes!!!! "In the short term, the market is a voting machine, BUT, in the long term, it is a weighing machine", Warren Buffet.

    IMGN continues to prove it WILL tip the scales to the LONGS.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • "On Wednesday, ImmunoGen (NASDAQ:IMGN) reported that Amgen (NASDAQ:AMGN) has licensed the exclusive right to use its maytansinoid TAP tech for the development of anticancer therapeutics to a third target whose identity is undivulged. In 2009, Amgen licensed rights for two other targets and has two compounds in clinical testing under those licenses. ImmunoGen is a biotechnology firm that develops anticancer therapeutics using its Targeted Antibody Payload tech and antibody expertise."

2.28+0.01(+0.44%)Oct 21 4:00 PMEDT